• AA
  • Share

Endocrine Society Launches New Open Access Journal Today

The Endocrine Society unveiled the first issue of its Open Access scholarly publication the Journal of the Endocrine Society (JES) today, marking the first time the Society has introduced a new journal under its ownership in nearly 30 years.

The online-only format is specifically intended to rapidly publish emerging science on a variety of endocrinology topics. The articles are available at no cost for non-commercial use to anyone in the world with an Internet connection.

The first issue of JES features research on post-treatment surveillance for thyroid cancer, pregnancy-induced Cushing’s syndrome, and advanced methods for measuring testosterone levels in saliva.

“Going forward, JES will undoubtedly play a central role in the dissemination of research and knowledge in our field.”

The peer-reviewed articles published in JES span the Society’s mission to cover advances in basic science, clinical science and clinical practice. JES includes original research as well as reports, mini-reviews, commentaries, tools and methods, datasets, and other innovative contributions that advance the endocrinology field.

“Going forward, JES will undoubtedly play a central role in the dissemination of research and knowledge in our field,” says Endocrine Society past-president J. Larry Jameson, MD, PhD, who serves as the journal’s first editor-in-chief, and is the executive vice president of the University of Pennsylvania for the Health System and Dean of the Perelman School of Medicine. “Publishing is rapidly transitioning from bound journals delivered by mail to online sources of information.”

The journal’s Open Access format allows the Society to publish high-quality scientific research papers without being restricted by the page limitations of a print journal. The new journal creates the opportunity for more scientists to publish their work and offers an avenue for cutting-edge research to advance science and improve medical care.

“Publishing is rapidly transitioning from bound journals delivered by mail to online sources of information.”

Readers will continually have access to new content from JES as each article is accepted after peer review and published online. This efficient process is designed to meet the needs of readers who want access to the latest science as well as researchers who want their work to be rapidly reviewed and shared with the public.

JES and digital editions of the Society’s other three journals — The Journal of Clinical Endocrinology & Metabolism, Endocrinology, and Endocrine Reviews – are now available exclusively through Oxford University Press (OUP) on its new, best-in-class, web platform. The platform allows for improved search and discovery with multimedia integration for optimal viewing on desktop computers, tablets or smartphones. The Society appointed OUP as its digital distributor in July 2016.

The Society also has begun providing published authors with access to Kudos and Altmetric — digital tools that help scientists and researchers to promote and gauge the reach of their published work in real time.


To learn more about JES or to submit a manuscript, visit https://academic.oup.com/jes.

You may also like

  • Endocrine Society Response to Immigration Order

    President Donald Trump signed an executive order on Friday, January 27, limiting refugees into the U.S., barring the citizens of seven countries – Iraq, Iran, Syria, Somalia, Sudan, Libya, and Yemen – from entering the U.S. on any visa category, and, consequently, also creating new barriers to the global exchange of scientific information. The order…

  • Rare Endocrine Diseases Highlighted in New Awareness Campaign

    A new global campaign has been launched by Alexion Pharmaceuticals, Inc., to raise awareness of bone disorder hypophosphatasia (HPP), metabolic disease lysosomal acid lipase deficiency (LAL-D), and other rare diseases. Uncommon Strength celebrates the extraordinary resilience and inner strength of individuals impacted by these diseases, according to a company statement. Aside from HPP and LAL-D, the…

Find more in